Company Filing History:
Years Active: 2022-2025
Title: Ilana Goldshtein: Innovator in Cancer Treatment
Introduction
Ilana Goldshtein is a prominent inventor based in Misgav, Israel. She has made significant contributions to the field of cancer treatment through her innovative research and development of monoclonal antibodies. With a total of 3 patents to her name, Goldshtein is recognized for her dedication to advancing medical science.
Latest Patents
Goldshtein's latest patents focus on methods of use for anti-ILT2 antibodies. The first patent provides monoclonal antibodies, or antigen-binding portions thereof, against ILT2, along with pharmaceutical compositions and methods of producing them. This invention also includes methods for treating cancer by administering these antibodies or compositions. The second patent similarly offers monoclonal anti-ILT2 antibodies and outlines methods for treating cancer, including patient selection strategies.
Career Highlights
Throughout her career, Ilana Goldshtein has worked with notable companies such as Biond Biologics Ltd. and Biond Biologies Ltd. Her work has been instrumental in developing therapies that target cancer more effectively, showcasing her commitment to improving patient outcomes.
Collaborations
Goldshtein has collaborated with several professionals in her field, including Tsuri Peretz and Dana Haves Ziv, who have contributed to her research endeavors.
Conclusion
Ilana Goldshtein's innovative work in the development of anti-ILT2 antibodies represents a significant advancement in cancer treatment. Her contributions continue to impact the medical community positively, paving the way for future breakthroughs in oncology.